Complete remission from recurrent EBV-positive lymphoma is not mandatory before HSCT to achieve long-term cure in a patient suffering from a recently described immunodeficiency affecting the T-cell coactivation molecule 4-1BB.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785803 | PMC |
| http://dx.doi.org/10.1016/j.clim.2020.108639 | DOI Listing |
Publication Analysis
Top Keywords
successful hematopoietic
4
hematopoietic stem
4
stem cell
4
cell transplantation
4
transplantation 4-1bb
4
4-1bb deficient
4
deficient patient
4
patient ebv-induced
4
ebv-induced lymphoproliferation
4
lymphoproliferation complete
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!